1. Home
  2. EFSC vs EVO Comparison

EFSC vs EVO Comparison

Compare EFSC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enterprise Financial Services Corporation

EFSC

Enterprise Financial Services Corporation

HOLD

Current Price

$56.46

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.99

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EFSC
EVO
Founded
1988
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.1B
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
EFSC
EVO
Price
$56.46
$2.99
Analyst Decision
Buy
Strong Buy
Analyst Count
3
1
Target Price
$65.67
$7.00
AVG Volume (30 Days)
133.0K
105.3K
Earning Date
01-26-2026
11-05-2025
Dividend Yield
2.25%
N/A
EPS Growth
8.68
N/A
EPS
5.13
N/A
Revenue
$646,694,000.00
$887,396,457.00
Revenue This Year
$20.14
N/A
Revenue Next Year
$5.15
$8.80
P/E Ratio
$11.07
N/A
Revenue Growth
9.31
N/A
52 Week Low
$45.22
$2.84
52 Week High
$62.60
$5.10

Technical Indicators

Market Signals
Indicator
EFSC
EVO
Relative Strength Index (RSI) 59.20 40.74
Support Level $55.09 $2.86
Resistance Level $58.25 $3.24
Average True Range (ATR) 1.31 0.10
MACD 0.32 0.01
Stochastic Oscillator 67.44 28.57

Price Performance

Historical Comparison
EFSC
EVO

About EFSC Enterprise Financial Services Corporation

Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate and consumer loans.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: